126 related articles for article (PubMed ID: 38411517)
1. Direct and Indirect Chimeric Antigen Receptor T-Cell Imaging with PET/MRI in a Tumor Xenograft Model.
Kim SY; Soh H; Jung JH; Cho EH; Kim H; Ju JM; Sheen JH; Lee SJ; Oh SJ; Lee SJ; Chung J; Ryu JS
Radiology; 2024 Feb; 310(2):e231406. PubMed ID: 38411517
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of real-time in vivo 89Zr-DFO-labeled CAR T-cell trafficking using PET imaging.
Lee SH; Soh H; Chung JH; Cho EH; Lee SJ; Ju JM; Sheen JH; Kim H; Oh SJ; Lee SJ; Chung J; Choi K; Kim SY; Ryu JS
PLoS One; 2020; 15(1):e0223814. PubMed ID: 31910217
[TBL] [Abstract][Full Text] [Related]
3. Spatio-temporal biodistribution of
Sta Maria NS; Khawli LA; Pachipulusu V; Lin SW; Zheng L; Cohrs D; Liu X; Hu P; Epstein AL; Jacobs RE
Sci Rep; 2021 Jul; 11(1):15077. PubMed ID: 34302002
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of in vivo CAR T cells tracking using streptavidin-biotin-paired positron emission tomography.
Pan D; Wang Y; Xu N; Xu Y; Wang X; Wang L; Yan J; Yu L; Miao L; Wang G; Yang M
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4419-4426. PubMed ID: 35902411
[TBL] [Abstract][Full Text] [Related]
5. Feasibility study of
Wang XY; Wang Y; Wu Q; Liu JJ; Liu Y; Pan DH; Qi W; Wang LZ; Yan JJ; Xu YP; Wang GJ; Miao LY; Yu L; Yang M
Acta Pharmacol Sin; 2021 May; 42(5):824-831. PubMed ID: 32901086
[TBL] [Abstract][Full Text] [Related]
6. Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.
Ugur O; Kothari PJ; Finn RD; Zanzonico P; Ruan S; Guenther I; Maecke HR; Larson SM
Nucl Med Biol; 2002 Feb; 29(2):147-57. PubMed ID: 11823119
[TBL] [Abstract][Full Text] [Related]
7. Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET.
Simonetta F; Alam IS; Lohmeyer JK; Sahaf B; Good Z; Chen W; Xiao Z; Hirai T; Scheller L; Engels P; Vermesh O; Robinson E; Haywood T; Sathirachinda A; Baker J; Malipatlolla MB; Schultz LM; Spiegel JY; Lee JT; Miklos DB; Mackall CL; Gambhir SS; Negrin RS
Clin Cancer Res; 2021 Feb; 27(4):1058-1068. PubMed ID: 33087332
[TBL] [Abstract][Full Text] [Related]
8. Site-specifically labeled
Kristensen LK; Christensen C; Jensen MM; Agnew BJ; Schjöth-Frydendahl C; Kjaer A; Nielsen CH
Theranostics; 2019; 9(15):4409-4420. PubMed ID: 31285769
[TBL] [Abstract][Full Text] [Related]
9. Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer.
Vázquez SM; Endepols H; Fischer T; Tawadros SG; Hohberg M; Zimmermanns B; Dietlein F; Neumaier B; Drzezga A; Dietlein M; Schomäcker K
Mol Imaging Biol; 2022 Feb; 24(1):115-125. PubMed ID: 34370181
[TBL] [Abstract][Full Text] [Related]
10. CD19 chimeric antigen receptor T cell therapy in leukemia xenograft mouse: Anti-leukemic efficacy, kinetics, and 4-week single-dose toxicity.
Kim JI; Park MY; Kwon E; Kang HJ; Kang BC
Toxicol Appl Pharmacol; 2023 Sep; 475():116628. PubMed ID: 37506978
[TBL] [Abstract][Full Text] [Related]
11. Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with
Leland P; Kumar D; Nimmagadda S; Bauer SR; Puri RK; Joshi BH
J Transl Med; 2023 Jun; 21(1):367. PubMed ID: 37286997
[TBL] [Abstract][Full Text] [Related]
12. PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with
Weist MR; Starr R; Aguilar B; Chea J; Miles JK; Poku E; Gerdts E; Yang X; Priceman SJ; Forman SJ; Colcher D; Brown CE; Shively JE
J Nucl Med; 2018 Oct; 59(10):1531-1537. PubMed ID: 29728514
[TBL] [Abstract][Full Text] [Related]
13. [Activity comparison of humanized CD19 CAR-T cells with murine CD19 CAR-T on Nalm-6 cells and xenograft tumor model].
Wang J; Mou N; Meng JX; Li X; Jiang YY; Yuan T; Deng Q
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):827-832. PubMed ID: 34407586
[No Abstract] [Full Text] [Related]
14. Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions.
Heidari P; Kunawudhi A; Martinez-Quintanilla J; Szretter A; Shah K; Mahmood U
Theranostics; 2018; 8(12):3380-3391. PubMed ID: 29930736
[TBL] [Abstract][Full Text] [Related]
15. ShRNA-mediated silencing of PD-1 augments the efficacy of chimeric antigen receptor T cells on subcutaneous prostate and leukemia xenograft.
Zhou JE; Yu J; Wang Y; Wang H; Wang J; Wang Y; Yu L; Yan Z
Biomed Pharmacother; 2021 May; 137():111339. PubMed ID: 33550044
[TBL] [Abstract][Full Text] [Related]
16. Imaging expression of the human somatostatin receptor subtype-2 reporter gene with 68Ga-DOTATOC.
Zhang H; Moroz MA; Serganova I; Ku T; Huang R; Vider J; Maecke HR; Larson SM; Blasberg R; Smith-Jones PM
J Nucl Med; 2011 Jan; 52(1):123-31. PubMed ID: 21149478
[TBL] [Abstract][Full Text] [Related]
17. 68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models.
Provost C; Prignon A; Cazes A; Combaret V; Delattre O; Janoueix-Lerosey I; Montravers F; Talbot JN
Anticancer Res; 2016 Sep; 36(9):4459-66. PubMed ID: 27630282
[TBL] [Abstract][Full Text] [Related]
18. A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing
Cho H; Al-Saden N; Lam H; Möbus J; Reilly RM; Winnik MA
Nucl Med Biol; 2020; 84-85():11-19. PubMed ID: 31931305
[TBL] [Abstract][Full Text] [Related]
19. Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with
Al-Saden N; Lam K; Chan C; Reilly RM
Mol Pharm; 2018 Aug; 15(8):3383-3393. PubMed ID: 29957952
[TBL] [Abstract][Full Text] [Related]
20. Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes.
Krebs S; Ahad A; Carter LM; Eyquem J; Brand C; Bell M; Ponomarev V; Reiner T; Meares CF; Gottschalk S; Sadelain M; Larson SM; Weber WA
J Nucl Med; 2018 Dec; 59(12):1894-1900. PubMed ID: 29903928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]